Including PRKACA/B fusions for detection of IOPN, and ALK, NTRK1/3, BRAF, RET gene fusions as potential therapeutic targets for PDAC
Including PRKACA/B fusions for detection of IOPN, and ALK, NTRK1/3, BRAF, RET gene fusions as potential therapeutic targets for PDAC
PancreaSeq is a product of the Molecular & Genomic Pathology Laboratory at the University of Pittsburgh Medical Center.